Log in to save to my catalogue

Liquid biopsy epigenomic profiling for cancer subtyping

Liquid biopsy epigenomic profiling for cancer subtyping

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10695830

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Although circulating tumor DNA (ctDNA) assays are increasingly used to inform clinical decisions in cancer care, they have limited ability to identify the transcriptional programs that govern cancer phenotypes and their dynamic changes during the course of disease. To address these limitations, we developed a method for comprehensive epigenomic pro...

Alternative Titles

Full title

Liquid biopsy epigenomic profiling for cancer subtyping

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10695830

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10695830

Other Identifiers

ISSN

1078-8956,1546-170X

E-ISSN

1546-170X

DOI

10.1038/s41591-023-02605-z

How to access this item